Studies associated with ontology term
MA:0002501   'plasma'     List measures

Data set	Procedure	What's in this data set	Panel	Sex	Age (weeks)	Year
Albers1	lipid profile with high-fat diet	Cholesterol, HDL, non-HDL, triglycerides, phospholipids. 4h fast, plasma. Baseline vs. high-fat diet (6wks).	inbred   (15)	both	6-14wks	1999
Albers1	protein activity assessment with high-fat diet	Phospholipid transfer protein activity. 4h fast.	inbred   (15)	both	6-14wks	1999
Attie2	hormone quantification with high-fat high-sucrose diet	Plasma insulin, adiponectin, leptin. Ex vivo insulin secretion.	DO population	both	4-26wks	2018
Auwerx2	metabolic panel with high-fat diet	Enzymes, creatinine, iron, lactate, urea.	inbred w/CC8	both	8-21 wks	2021
Auwerx2	lipid profile with high-fat diet	Cholesterol, HDL, LDL, triglycerides, free fatty acids.	inbred w/CC8	both	8-21 wks	2021
Bautz1	study archive	Plasma lipids. Cholesterol, triglycerides.	QTL population	both	12-14wks	2013
Beamer2	study archive	Bone morphology and strength, insulin-like growth factor 1.	QTL population	f	16wks	2001
Bennett4	metabolic panel	Plasma enzymes, creatinine, glucose, urea, metabolic health score.		both	8-20wks	2021
Bennett4	lipid profile	Cholesterol, non-esterified fatty acids, triglyceride.		both	8-20wks	2021
Bennett4	biomarker quantification	TMAO, choline, phosphocholine, glycerophosphocholine, betaine, carnitine.		both	8-20wks	2021
Bennett4	hormone quantification	Insulin, glucose:insulin ratio.		both	8-20wks	2021
Berndt3	metabolite quantification	Vitamin D concentration (serum).	inbred   (18)	m	11wks	2011
Brockmann1	study archive	Body, organ weights, litter size, abdominal fat, lipids, insulin, leptin.	QTL population	both	3-6wks	2009
CGDpheno1	metabolic panel	Clinical blood chemistry (plasma). 4h fast.	inbred w/CC8   (72)	both	10-13wks	2009
CGDpheno1	lipid profile	Cholesterol, HDL, triglycerides, free fatty acids. 4h fast, plasma.	inbred w/CC8   (72)	both	10-13wks	2009
CGDpheno3	metabolic panel	Glucose (plasma). 4h fast.	CC diallel w/par   (62)	both	8-16wks	2012
CGDpheno3	lipid profile	Cholesterol, HDL, triglycerides. 4h fast, plasma.	CC diallel w/par   (62)	both	8-16wks	2012
Chesler2	metabolic panel	Clinical blood chemistry. 16h fast.	CC diallel w/par   (62)	both	7-15wks	2011
Chesler3	metabolic panel	Clinical blood chemistry. 16h fast.	CC pre w/par   (367)	both	7-15wks	2011
Cheverud1	lipid profile with high-fat diet	Cholesterol, triglycerides, free fatty acids. High-fat diet (17wks) vs. control. 4h fast, serum.	LGXSM w/par   (19)	both	12-16wks	2004
Cheverud1	hormone quantification with high-fat diet	Insulin, leptin.	LGXSM w/par   (19)	both	12-16wks	2004
Cowell1	hormone quantification with Staphylococcus aureus	Interleukin 6 levels (serum) after infection with Staphylococcus aureus. Kidney and peritoneal fluid.	inbred   (13)	f	8wks	2012
Crowley1	drug and metabolite quantification with haloperidol	Haloperidol concentration (plasma). Baseline vs. during and after haloperidol 60d implant (several timepoints).	inbred w/CC8   (27)	m	9-28wks	2012
Donahue1	metabolic panel	Thyroxine (serum).	inbred w/CC7   (30)	both	15-16wks	2002
Donahue1	hormone quantification	Osteocalcin, insulin-like growth factor 1.	inbred w/CC7   (30)	both	15-16wks	2002
Donahue7	immunoglobulin quantification	Immunoglobulin concentrations (plasma).	B6.A consomic w/par   (22)	both	9wks	2012
Donahue8	immunoglobulin quantification	Immunoglobulin concentrations (plasma).	B6.PWD consomic w/par   (28)	both	9wks	2011
Donahue9	metabolic panel	Clinical blood chemistry (serum). 4h fast.	B6.PWD consomic w/par   (25)	both	11wks	2011
Eumorphia1	lipid profile	Cholesterol, HDL, non-HDL, triglycerides, free fatty acids. Plasma.	inbred   (8)	both	12wks	2007
Eumorphia1	metabolic panel	Clinical blood chemistry (plasma). Unknown fast.	inbred   (8)	both	12wks	2007
Eumorphia7	immunoglobulin quantification	Immunoglobulin concentrations (serum).	inbred   (6)	both	9-12wks	2008
Farmer1	study archive	Colitis susceptibility, severity. Colon histopathology, body and spleen weight.	QTL population	both	6wks	2001
GMC06	metabolic panel	Glucose, glycerol. 16h fast.	inbred   (5)	both	10-11wks	2020
GMC06	lipid profile	Cholesterol, HDL, non-HDL, triglycerides, fatty acids. 16h fast, plasma.	inbred   (5)	both	10-11wks	2020
GMC16	metabolic panel	Clinical blood chemistry (plasma). No fast.	inbred w/CC8   (8)	both	16-17, 20-21wks	2020
GMC16	lipid profile	Cholesterol, triglycerides. No fast, plasma.	inbred w/CC8   (8)	both	16-17, 20-21wks	2020
GMC20	immunoglobulin quantification	Immunoglobulins (plasma).	inbred w/CC8   (8)	both	16-17, 20-21wks	2020
GMC20	autoantibody quantification	Anti-DNA autoantibodies, rheumatoid factor.	inbred w/CC8   (8)	both	16-17, 20-21wks	2020
Gould1	drug and metabolite quantification with lithium	Lithium concentration in brain tissue and blood serum after lithium (several doses).	inbred   (11)	m	7-8wks	2011
Gould2	drug and metabolite quantification with nicotine	Amount of nicotine and cotinine in blood plasma after nicotine doses. High and lower doses.	inbred   (8)	m	8-12wks	2011
Harrill1	metabolic panel with isoniazid	Alanine transaminase. Isoniazid-treated vs. control.	inbred   (34)	f	8-10wks	2011
Harrill2	metabolic panel with DB289	Blood urea nitrogen, alanine transaminase, creatinine. DB289-treated vs. control.	inbred   (34)	f	6-8wks	2012
HMDPpheno2	lipid profile	Cholesterol, HDL, non-HDL, triglycerides, free fatty acids. 16h fast, plasma.	HMDP   (99)	m	16wks	2010
Ishimori1	study archive with high-fat diet	Lipids, atherosclerosis lesions, parathyroid hormone after high-fat diet.	QTL population	f	20wks	2004
JaxCC1	hormone quantification	Insulin (plasma).	CC   (18)	both	various	2018
JaxKOMP-EAP	glucose tolerance	0 to 120 min after 20% glucose i.p., 16h fast.	KOMP	both	8-18wks	2021
JaxKOMP-EAP	lipid profile	Cholesterol, HDL, triglycerides, fatty acids. 4h fast, plasma.	KOMP	both	8-18wks	2021
JaxKOMP-EAP	metabolic panel	Clinical blood chemistry (plasma). No fast.	KOMP	both	8-18wks	2021
JaxKOMP-EAP	hormone quantification	Insulin (plasma).	KOMP	both	8-18wks	2021
JaxKOMP-LAP	glucose tolerance	0 to 120 min after 20% glucose i.p., 16h fast.	KOMP	both	66-81wks	2021
JaxKOMP-LAP	metabolic panel	Clinical blood chemistry (plasma). No fast.	KOMP	both	66-81wks	2021
Jaxpheno3	metabolic panel	Clinical blood chemistry (plasma). 4h fast.	inbred   (11)	both	8, 16 wks	2006
Jaxpheno3	lipid profile	Cholesterol, HDL, triglycerides, free fatty acids. 4h fast, plasma.	inbred   (11)	both	8, 16 wks	2006
Lake1	metabolic panel	Glucose, bilirubin, aspartate transaminase (plasma). 4h fast.	B6.A consomic w/par   (23)	both	7-11wks	2005
Lake1	lipid profile	Cholesterol, HDL, triglycerides, fatty acids. 4h fast, plasma.	B6.A consomic w/par   (23)	both	7-11wks	2005
Leiter2	study archive	Type 1 diabetes development study.	QTL population	f	14-40wks	2009
Li1	study archive with western diet	Lipids, atherosclerosis lesion histopathology. High-fat, western-style diet.	QTL population	f	12wks	2008
Lyons1	study archive with high-fat diet	Lipids (plasma), liver weight, gallbladder and gallstone histopathology.	QTL population	m	16-18wks	2003
Lyons2	study archive with high-fat diet	Lipids (plasma), bile, liver weight, gallbladder and gallstone histopathology.	QTL population	m	16-18wks	2003
Lyons3	study archive with high-fat diet	Lipids, gallbladder and gallstone histopathology after high-fat diet.	QTL population	m	14-20wks	2004
Nadeau2	metabolic panel with high-fat high-sucrose diet	Glucose, insulin, insulin resistance after 16wks of high-fat high-sucrose diet. 16h fast.	B6.A consomic w/par   (24)	m	5, 21 wks	2015
Nadeau2	lipid profile with high-fat high-sucrose diet	Cholesterol, triglycerides. 16h fast, plasma. Hepatic triglycerides.	B6.A consomic w/par   (24)	m	5, 21 wks	2015
Nadeau3	hormone quantification with high-fat high-sucrose diet	Insulin and insulin resistance after 16 wks of high-fat high-sucrose diet. Overnight fast.	inbred   (2)	m	21 wks	2016
Nadeau3	lipid profile with high-fat high-sucrose diet	Cholesterol and triglycerides. Overnight fast, plasma. Hepatic triglycerides.	inbred   (2)	m	21 wks	2016
Naggert1	metabolic panel with high-fat diet	Glucose (plasma). Baseline vs. high-fat diet (17wks). 4h fast.	inbred w/CC7   (43)	both	5, 21 wks	2003
Naggert1	hormone quantification with high-fat diet	Insulin and leptin after 18wks on high-fat diet. Multiple readings per animal were averaged.	inbred w/CC7   (43)	both	5, 21 wks	2003
Noll1	immunoglobulin quantification	IgM, IgG1, IgG2a + IgG2c, IgG2b, IgG3, total IgG	CC RIX   (46)	f	8-12 wks of age	2020
Paigen1	lipid profile with high-fat diet	Cholesterol, HDL, non-HDL. 4h fast, plasma. Hepatic lipids. 8wks on high-fat diet.	inbred   (44)	both	15-19wks	2000
Paigen1	metabolic panel with high-fat diet	Alanine transaminase, bile salts (plasma) after 8wks on high-fat diet. 4h fast.	inbred   (44)	both	15-19wks	2000
Paigen2	lipid profile with high-fat diet	Cholesterol, HDL, non-HDL, triglycerides. Baseline vs. high-fat diet (17wks). 4h fast, plasma.	inbred w/CC7   (43)	both	7-9wks, 24-27wks	2002
Paigen3	lipid profile with high-fat diet	Cholesterol, HDL, non-HDL. 4h fast, plasma. Hepatic lipids. 8wks on high-fat diet.	obesity mutants   (8)	both	15-19wks	2000
Paigen3	metabolic panel with high-fat diet	Alanine transaminase, bile salts (plasma) after 8wks on high-fat diet. 4h fast.	obesity mutants   (8)	both	15-19wks	2000
Paigen4	lipid profile	Cholesterol, HDL, non-HDL, triglycerides. 4h fast, plasma.	inbred w/CC7   (43)	both	10wks	2002
Pitman1	study archive with high-fat diet	Cholesterol (plasma) after high-fat diet (several timepoints).	QTL population	f	6-26wks	2002
Pletcher1	hormone quantification	Corticosterone (serum).	inbred   (32)	m	7-9wks	2007
Reifsnyder1	study archive	Body weight (several ages), fat mass, body mass index, fat pad weights.	QTL population	m	4-24wks	2000
Richards-Smith1	study archive with macronutrient diet option	Caloric intake, glucose, body and fat pad weights. Macronutrient diet option.	QTL population	m	8-13wks	2002
RIKEN-EAD1	metabolic panel	Clinical blood chemistry (plasma). 4h fast.	inbred RBRC   (56)	both	8, 12 wks	2008
RIKEN-EAD1	lipid profile	Cholesterol, HDL, triglycerides. 4h fast, plasma.	inbred RBRC   (56)	both	8, 12 wks	2008
RIKEN-EAD2	metabolic panel	Clinical blood chemistry (plasma). 4h fast.	wild-derived RBRC   (33)	both	8, 12 wks	2008
RIKEN-EAD2	lipid profile	Cholesterol, HDL, triglycerides. 4h fast, plasma.	wild-derived RBRC   (33)	both	8, 12 wks	2008
Rusyn2	metabolic panel with trichloroethylene	Blood urea nitrogen, alanine transaminase, aspartate transaminase (serum). Baseline and trichloroethylene-exposed (several timepoints). No fast.	inbred   (17)	m	7wks	2010
Rusyn2	drug and metabolite quantification with trichloroethylene	Trichloroethylene metabolites in serum, 2h, 4h, 24h after trichoroethylene exposure.	inbred   (17)	m	7wks	2010
Rusyn5	metabolic panel with high-fat diet and ethanol	Alanine transaminase (serum) after 4wk regimen of ethanol vs. control, both groups on high-fat diet. 24h fast.	inbred   (14)	m	8-14wks	2011
Rusyn5	metabolite quantification with high-fat diet and ethanol	Homocysteine concentration after 4wk regimen of ethanol vs. control, both groups on high-fat diet. 24h fast.	inbred   (14)	m	8-14wks	2011
Rusyn6	metabolic panel with trichloroethylene	Blood urea nitrogen (serum). Trichloroethylene-exposed vs. control.	inbred   (7)	m	6-7wks	2014
Rusyn6	drug and metabolite quantification with trichloroethylene	Trichloroethylene metabolite in blood, liver, kidney after trichloroethylene exposure.	inbred   (7)	m	6-7wks	2014
Schoenrock1	hormone quantification with various diets	Serum corticosterone at baseline and 10 mins after stress. Comparison of 4 diets.	CC RIX   (18)	f	8-9 wks	2018
Schonfeld1	lipid profile	Cholesterol, triglycerides, free fatty acids, phospholipids. 5h fast, plasma. Hepatic triglycerides.	inbred   (11)	both	8-10wks	2005
Schonfeld1	metabolic panel	Glucose, beta-hydroxybutyrate (plasma). No fast.	inbred   (11)	both	8-10wks	2005
Schonfeld1	hormone quantification	Insulin level, 30 min post-injection in glucose tolerance test. 10% glucose. 5h fast.	inbred   (11)	both	8-10wks	2005
Schoonjans1	biomarker quantification with high-fat diet	Bile acid levels in plasma, feces, and liver.	BXD w/par   (36)	m	8-29 wks	2022
Shockley1	lipid profile with high-fat diet	Cholesterol, HDL, triglycerides, fatty acids. High-fat diet (4wks) vs. control. 5h fast, serum.	inbred   (10)	both	10-13wks	2008
Shockley1	metabolic panel with high-fat diet	Clinical blood chemistry measures (serum). High-fat diet (4wks) vs. control.	inbred   (10)	both	10-13wks	2008
Solberg1	study archive	Open field test, forced swim test, defensive burying task.	QTL population	both	11-17wks	2004
Stylianou2	study archive	Lipids. Cholesterol, triglycerides, body weight.	QTL population	both	8-10wks	2006
Su2	study archive with high-fat diet	Lipids (plasma). Cholesterol, triglycerides, aortic lesions, body mass index.	QTL population	f	14wks	2009
Svenson3	metabolic panel	Glucose, bilirubin, blood urea nitrogen, aspartate transaminase (plasma). 4h fast.	B6.PWD consomic w/par   (28)	both	9wks	2006
Svenson3	lipid profile	Cholesterol, HDL, triglycerides, free fatty acids. 4h fast, plasma.	B6.PWD consomic w/par   (28)	both	9wks	2006
Threadgill1	metabolic panel with acetaminophen	Blood urea nitrogen, alanine transaminase, aspartate transaminase (serum), liver enzyme homeostasis. Acetaminophen (several doses) vs. control, several timepoints post-Rx. 18h fast.	inbred w/CC7   (37)	m	8-17wks	2005
Threadgill2	metabolic panel with acetaminophen	Alanine transaminase (serum). Acetaminophen (several doses) vs. control.	inbred   (5)	m	6-8wks	2005
Threadgill2	drug and metabolite quantification with acetaminophen	Acetaminophen metabolite concentrations (serum) and liver protein homeostasis. Baseline vs. acetaminophen (several doses, several timepoints).	inbred   (5)	m	6-8wks	2005
Tordoff3	metabolic panel	Ionized and total blood calcium, blood pH.	inbred w/CC7   (40)	both	9-15wks	2002
Trullas1	hormone quantification	Corticosterone levels (plasma). Baseline vs. after stress (30 min in restraining cage).	inbred   (16)	m	6-8wks	1993
Vulpe1	transferrin quantification	Diferric transferrin (plasma).	inbred   (18)	both	8wks	2010
Wang1	study archive with high-fat diet	Lipids (plasma). Cholesterol, inducibility, triglycerides, atherosclerosis lesions.	QTL population	f	10-23wks	2003
Wiltshire2	drug and metabolite quantification with fluoxetine	Fluoxetine and norfluoxetine concentration (serum) after fluoxetine.	inbred   (30)	m	9-11wks	2011
Wittenburg2	study archive with high-fat diet	Lipids (plasma), liver weight, gallbladder and gallstone histopathology.	QTL population	both	6-16wks	2003
Wittenburg3	study archive with high-fat diet	Lipids (plasma), liver weight, gallbladder and gallstone histopathology.	QTL population	both		2005
Xenakis1	drug and metabolite quantification	Plasma haloperidol concentration.	CC RIX   (73)	both	7-13wks	2020
Yuan1	hormone quantification	Insulin-like growth factor 1 (serum). Aging study, 6mo, 12mo, and 18mo.	inbred   (33)	both	26, 52, 78 wks	2007
Yuan3	metabolic panel	Clinical blood chemistry. Aging study, 6mo, 12mo, 18mo.	inbred   (32)	both	26, 52, 78 wks	2008
Yuan3	lipid profile	Cholesterol (HDL). Aging study, 6mo, 12mo, 18mo. 4h fast, plasma.	inbred   (32)	both	26, 52, 78 wks	2008
Yuan5	study archive	Plasma levels of P-selectin and soluble vascular cell adhesion molecule-1.	QTL population	f	18wks	2008
Zhang1	study archive with western diet	Atherosclerosis and glucose homeostasis. Lesions, lipids, glucose, insulin. High-fat, western-style diet.	QTL population	f	<6-18wks	2012